— Know what they know.
Not Investment Advice
Also trades as: CYAD (NASDAQ) · $vol 0M · CYAD.BR (BRU) · $vol 0M · 0QFK.L (LSE) · $vol 0M

CLYYF OTC

Celyad Oncology S.A.
1W: +0.0% 1M: +0.0% 3M: +12.0% YTD: +86.7% 1Y: -31.7% 3Y: -99.4%
$0.28
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $12.5M mcap · 44M float · 0.0000% daily turnover

📊 Key Metrics

TTM
$0M
Revenue
+102.9% YoY
$-5M
Net Income
+88.0% YoY
$-11M
Free Cash Flow
+75.8% YoY
30417.0%
Gross Margin
-49016.9%
Op. Margin
64360.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-114.9%
ROA-48.8%
ROIC-1433.2%

Valuation

P/E2.7
P/B8.0
EV/EBITDA0.0

Leverage

Debt/Equity0.00
Current Ratio1.92
Interest Cov.-70.9x

Quality Scores

Piotroski F4/9
Altman Z—
Beneish M15.32

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms